MedPath

Intraocular Pressure Control After Anterior Segment Laser - Comparison Between 2 Drugs

Not Applicable
Conditions
Glaucoma, Narrow Angle
Interventions
Procedure: YAG laser peripheral iridotomy
Registration Number
NCT01417858
Lead Sponsor
Universidade Federal do Paraná
Brief Summary

The purpose of this study is to compare the intra-ocular (IOP) control efficacy between brimonidine 0.1% vs. 0.2% after laser peripheral iridotomy (LPI).

Detailed Description

Postoperative IOP elevation is one of the most common complications after LPI.Previous studies showed that brimonidine 0.2% is effective in blunting IOP spikes after LPI.This prospective randomized double-masked interventional study will include patients with bilateral narrow angles, defined by irido-trabecular contact in \>180o on gonioscopy.Pilocarpine 1% will be used in both eyes, and 30 minutes later, brimonidine 0.1% randomly used in one eye and brimonidine 0.2% in the contra-lateral eye. LPI with Nd:YAG laser is performed 30 minutes later in both eyes by a single glaucoma specialist. IOP measurements are assessed before the use of any eyedrop (basal IOP), 30 minutes after pilocarpine (pre-brimonidine), and 30, 60, 120, 180 minutes after LPI. Pachymetry, ultrasonic biometry, gonioscopy, and total YAG laser energy are recorded. Non-parametric test will be used for analysis.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • bilateral narrow angles, defined by irido-trabecular contact in >180o on gonioscopy
Exclusion Criteria
  • previous cataract surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
brimonidine 0.2%YAG laser peripheral iridotomy-
brimonidine 0.1%YAG laser peripheral iridotomy-
Primary Outcome Measures
NameTimeMethod
intra-ocular pressure increaseone year

mean intra-ocular pressure increase after laser peripheral iridotomy

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Universidade Federal do Parana

🇧🇷

Curitiba, Parana, Brazil

© Copyright 2025. All Rights Reserved by MedPath